To the Editor: In the absence of randomized clinical trials, comparative effectiveness research plays a critical role in evaluating new technologies. However, because these studies invariably rely on observational data, the devil is in the details.
The recent study by Dr Sheets and colleagues1 related to the comparative effectiveness of radiation therapy modalities for prostate cancer highlights this concern in 2 ways. The first relates to treatment assignment, or in this case, the type of radiation. The authors broadly assigned patients to conformal therapy (the predecessor to intensity-modulated radiation therapy [IMRT] and proton beam), invariably including patients with conventional, stereotactic, and neutron beam therapies. It is established in randomized trials that conventional therapy is associated with greater morbidity and is less effective than conformal radiation for prostate cancer.2 In fact, the use of conventional therapy during the period of study was significant.3 Given the relatively small effect size described in the article, such misclassification might explain the observed differences. An alternative approach would have been to incorporate treatment planning codes specific to conformal therapy to obtain a more homogenous comparison group.3,4
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.